15th Aug 2014 06:52
LONDON (Alliance News) - Oxford BioMedia PLC said Friday that it has appointed Dr Paul Blake, a non-executive director, to the executive management team as chief development officer.
The appointment takes effect September 1, 2014, said the company. In the new role Blake will remain a member of the board and will assume responsibility for the clinical development of Oxford BioMedica's pipeline of gene and cell therapies.
Blake has been with Oxford BioMedica since January 2010 and has more than 30 years' experience in roles in international pharmaceutical and biotech companies.
By Alice Attwood; [email protected]; @AliceAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica